Acadia Healthcare (ACHC) Tops Q3 EPS by 2c; Offers FY23 Guidance

Acadia Healthcare (NASDAQ: ACHC) reported Q3 EPS of $0.91, $0.02 better than the analyst estimate of $0.89. Revenue for the quarter came in at $750.3 million versus the consensus estimate of $726.24 million.

GUIDANCE:

Acadia Healthcare sees FY2023 EPS of $3.33-$3.43, versus the consensus of $3.41. Acadia Healthcare sees FY2023 revenue of $2.9-2.92 billion, versus the consensus of $2.89 billion.

For earnings history and earnings-related data on Acadia Healthcare (ACHC) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• John Wiley & Sons, Inc. (WLYB) Tops Q4 EPS by 12c; Offers Outlook
• Morgan Stanley sees little room left in steel rally, cuts Cleveland-Cliffs rating